During the past decade, Klaipeda Republican Hospital, Public Institution conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klaipeda Republican Hospital, Public Institution" #1 collaborator was "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klaipeda Republican Hospital, Public Institution" are "Colitis, Ulcerative" (3 trials), "Atrial Fibrillation" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Klaipeda Republican Hospital, Public Institution" in a lesser frequency.

Most popular intervention types in "Klaipeda Republican Hospital, Public Institution" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials), "Edoxaban" (1 trials), "Placebo IV" (1 trials) and "Placebo SC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klaipeda Republican Hospital, Public Institution" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Klaipeda Republican Hospital, Public Institution". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klaipeda Republican Hospital, Public Institution, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klaipeda Republican Hospital, Public Institution, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".